Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Baxter

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of Cardiovascular Pharmacology|August 3, 2001
Delayed or second window preconditioning induced by adenosine A1 receptor activation is independent of early generation of nitric oxide or late induction of inducible nitric oxide synthaseA Dana, G F Baxter, D M Yellon
British Journal of Pharmacology|August 19, 2007
Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signalingD S Burley, P Ferdinandy, G F Baxter
Journal of Cardiovascular Pharmacology|February 10, 1998
Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivoJ Imagawa, G F Baxter, D M Yellon
Cardiovascular Drugs and Therapy|May 27, 2004
Omapatrilat limits infarct size and lowers the threshold for induction of myocardial preconditioning through a bradykinin receptor-mediated mechanismZ Ebrahim, G F Baxter, D M Yellon
Heart (British Cardiac Society)|February 17, 2001
Exercise directly enhances myocardial tolerance to ischaemia-reperfusion injury in the rat through a protein kinase C mediated mechanismN Yamashita, G F Baxter, D M Yellon
American Journal of Physiology. Heart and Circulatory Physiology|August 22, 2001
Bradykinin elicits "second window" myocardial protection in rat heart through an NO-dependent mechanismZ Ebrahim, D M Yellon, G F Baxter
Cardiovascular Drugs and Therapy|February 2, 1999
Reduction of infarct size in isolated rat heart by CsA and FK506: possible role of phosphatase inhibitionQ Cai, G F Baxter, D M Yellon
Pharmacology & Therapeutics|January 1, 1996
Protection of the myocardium by ischaemic preconditioning: mechanisms and therapeutic implicationsC G Millar, G F Baxter, C Thiemermann
British Journal of Pharmacology|April 3, 1999
Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioningJ Imagawa, D M Yellon, G F Baxter
Journal of Molecular and Cellular Cardiology|July 1, 1997
Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbitJ i Imagawa, G F Baxter, D M Yellon
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of Cardiovascular Pharmacology|August 3, 2001
Delayed or second window preconditioning induced by adenosine A1 receptor activation is independent of early generation of nitric oxide or late induction of inducible nitric oxide synthaseA Dana, G F Baxter, D M Yellon
British Journal of Pharmacology|August 19, 2007
Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signalingD S Burley, P Ferdinandy, G F Baxter
Journal of Cardiovascular Pharmacology|February 10, 1998
Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivoJ Imagawa, G F Baxter, D M Yellon
Cardiovascular Drugs and Therapy|May 27, 2004
Omapatrilat limits infarct size and lowers the threshold for induction of myocardial preconditioning through a bradykinin receptor-mediated mechanismZ Ebrahim, G F Baxter, D M Yellon
Heart (British Cardiac Society)|February 17, 2001
Exercise directly enhances myocardial tolerance to ischaemia-reperfusion injury in the rat through a protein kinase C mediated mechanismN Yamashita, G F Baxter, D M Yellon
American Journal of Physiology. Heart and Circulatory Physiology|August 22, 2001
Bradykinin elicits "second window" myocardial protection in rat heart through an NO-dependent mechanismZ Ebrahim, D M Yellon, G F Baxter
Cardiovascular Drugs and Therapy|February 2, 1999
Reduction of infarct size in isolated rat heart by CsA and FK506: possible role of phosphatase inhibitionQ Cai, G F Baxter, D M Yellon
Pharmacology & Therapeutics|January 1, 1996
Protection of the myocardium by ischaemic preconditioning: mechanisms and therapeutic implicationsC G Millar, G F Baxter, C Thiemermann
British Journal of Pharmacology|April 3, 1999
Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioningJ Imagawa, D M Yellon, G F Baxter
Journal of Molecular and Cellular Cardiology|July 1, 1997
Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbitJ i Imagawa, G F Baxter, D M Yellon
Pageof 7